Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-21-033287

President and CEO acquired 19,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stergiou Angelos M. President and CEO 2021-03-04 Grant or award +19,750 98,287 D
Derivatives
Stergiou Angelos M. President and CEO 2021-03-04 Grant or award · Stock Option (Right to Buy) +118,500 118,500 D
Loading xslF345X03/tm218923-1_4.xml…